Dash Bio raised $6.5M in Seed funding led by Freestyle Capital to expand operations and development efforts in tech-enabled drug development services.
Dash Bio raised $6.5M in Seed funding led by Freestyle Capital to expand operations and development efforts in tech-enabled drug development services.
10/28/24, 1:05 PM
Location
bostonMoney raised
$6.5 million
Industry
biotechnology
Round Type
seed
Investors
Life X Ventures, Swift Ventures, Freestyle Capital
Dash Bio, based in Newton, MA, raised $6.5M in Seed funding. The round was led by Freestyle Capital, with participation from Swift Ventures, LifeX Ventures, and other private investors.
Company Info
Location
56 broad street
boston, massachusetts, united states
Additional Info
At Dash Bio, we're revolutionizing clinical bioanalysis to expedite drug development. By leveraging AI and robotics, we deliver higher-quality assays with turnaround times up to 10x faster than the industry average for clinical trials and GLP studies.